Public health

  • Nerve-zapping stimulator ‘could help improve fitness,’ study finds

    An ear-worn device that stimulates a major nerve has been shown to improve exercise performance in an early-stage trial involving healthy volunteers. The device sends gentle electrical pulses to the vagus nerve – which runs from the brain to the heart and helps regulate heart function – for 30 minutes a day. Participants who wore [...]

  • Game will help young people navigate adversity

    A serious video game developed in Cornwall aims to help young people explore mental health challenges linked to adverse childhood experiences such as bereavement or poverty. The Ace of Hearts game is part of ATTUNE, a £35m UK-wide programme using arts-based methods, including gaming, to explore how negative early experiences affect mental health. Developers at [...]

  • New breast screening trial aims to detect cancer earlier

    A UK study is investigating whether Fast MRI scans can detect breast cancer earlier than mammograms in women with average breast density. The Fast MRI Dyamond study will scan around 1,000 women aged 50 to 52 across six NHS sites including Cheltenham, Swindon and Truro over the next three and a half years. The Fast [...]

  • Hospitals can now make cancer therapies on-site

    New UK rules allow hospitals to prepare advanced blood cancer treatments locally, reducing delays for patients. New regulations introduced on 23 July will allow hospitals across the UK to manufacture personalised cancer therapies on-site, instead of sending cells to distant labs. The Medicines and Healthcare products Regulatory Agency (MHRA) has created the legal framework, said [...]

  • Self-test kits sold in shops lack accuracy, study finds

    Many off-the-shelf self-test kits claim to detect conditions but offer little or no evidence to support their accuracy, researchers have found. Researchers from the University of Birmingham purchased 30 self-test kits in 2023 from UK supermarkets, pharmacies and health shops. The kits included tests for bowel cancer, blood cholesterol, menopause and vitamin deficiency — conditions [...]

  • UK ambulance service pilots live video CPR coaching

    East of England Ambulance Service has become the first in the UK to offer live video guidance for 999 callers reporting cardiac arrests. The East of England Ambulance Service Trust (EEAST) will use live video to help bystanders perform cardiopulmonary resuscitation (CPR) — chest compressions and rescue breaths to restart the heart — following a [...]

  • From breakthrough to bedside: Closing the myeloma delivery gap in the NHS

    By Sanius Health The treatment landscape for multiple myeloma is changing fast, and for the better. For patients who have relapsed or exhausted their options, there is now a renewed sense of hope. Chimeric Antigen Receptor Therapies (CAR-T) and bispecific antibodies (BsAbs) are transforming outcomes in ways that were once unimaginable. Trispecific antibodies (TsAbs) are [...]

  • WATCH: Protecting health data in the age of cyber threats

    From ransomware to insider threats, the healthcare sector faces an unprecedented surge in cyber attacks that can compromise privacy, disrupt care and carry massive financial consequences. And as digital transformation accelerates and the use of AI, cloud services, remote care and connected devices expands, so too does the surface area for potential attack. In this [...]

  • UK to ban ransom payments by public bodies

    The UK government plans to ban public bodies from paying ransoms to hackers, while private companies must inform authorities if they intend to meet ransom demands. The measures were announced on Tuesday by home office security minister Dan Jarvis and are intended to signal to cybercriminals that the UK is united in its stance against [...]

  • NHS rolls out RSV jab for 7,000 premature babies

    The NHS will give 7,000 premature babies in England a new RSV jab that offers protection against the common respiratory virus this winter. From late September, around 7,000 high-risk infants and babies born before 32 weeks this year will receive a single dose of nirsevimab, which provides six months’ protection against respiratory syncytial virus (RSV). [...]